Literature DB >> 24678746

Povidone iodine in the treatment of adenoviral conjunctivitis in infants.

Zuhal Özen Tunay1, Ozdemir Ozdemir, Ikbal Seza Petricli.   

Abstract

CONTEXT: Adenoviral conjunctivitis.
OBJECTIVE: To examine the effects of conjunctival irrigation with povidone iodine in infants with adenoviral conjunctivitis.
MATERIAL AND METHODS: An outbreak of adenovirus conjunctivitis occurred between September and December 2012 at the neonatal intensive care unit of our hospital. Forty-three infants with adenoviral conjunctivitis were examined in this study. Thirty-five eyes of 35 infants who had detailed ophthalmological examination and clinical scoring were included. The conjunctiva of 15 infants (Group 1) were irrigated with povidone iodine 2.5% solution and then treated with preservative-free artificial tears and preservative-free antibiotic drops. Twenty infants (Group 2) were treated only with the same drops with the same posology, without conjunctival irrigation with povidone iodine. Patients were examined two times a week until the complete recovery. Lid edema, conjunctival chemosis, fragility of conjunctival vasculature, pseudomembrane formation, and corneal involvement were scored clinically.
RESULTS: Twenty patients (57%) were female and 15 patients (43%) were male and mean age was 3.1 months (ranged from 1 to 4 months). No relation was found between gender and clinical scores. Statistically significant lower clinical scores were obtained from Group 1. The median recovery time was earlier in Group 1 (7 d) than Group 2 (12 d) (p = 0.001).
CONCLUSION: Conjunctival irrigation with 2.5% povidone iodine is effective in the treatment of adenoviral conjunctivitis in infants.

Entities:  

Keywords:  Adenovirus; epidemic keratoconjunctivitis; infants; povidone iodine; pseudomembrane

Mesh:

Substances:

Year:  2014        PMID: 24678746     DOI: 10.3109/15569527.2014.888077

Source DB:  PubMed          Journal:  Cutan Ocul Toxicol        ISSN: 1556-9527            Impact factor:   1.820


  7 in total

1.  Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.

Authors:  Ellen Shorter; Meredith Whiteside; Jennifer Harthan; Mathew S Margolis; Andrew T Hartwick; Spencer Johnson; Mary Migneco; Christina Morettin; Christian K Olson; Julia Huecker; Tammy Than; Mae O Gordon
Journal:  Ocul Surf       Date:  2019-08-08       Impact factor: 5.033

2.  Povidone iodine treatment is deleterious to human ocular surface conjunctival cells in culture.

Authors:  William Swift; Jeffrey A Bair; Wanxue Chen; Michael Li; Sole Lie; Dayu Li; Menglu Yang; Marie A Shatos; Robin R Hodges; Miriam Kolko; Tor P Utheim; Wendell Scott; Darlene A Dartt
Journal:  BMJ Open Ophthalmol       Date:  2020-09-16

Review 3.  Mystery eye: Human adenovirus and the enigma of epidemic keratoconjunctivitis.

Authors:  Rahul A Jonas; Lawson Ung; Jaya Rajaiya; James Chodosh
Journal:  Prog Retin Eye Res       Date:  2019-12-28       Impact factor: 21.198

4.  Treatment for retinopathy of prematurity in an infant with adenoviral conjunctivitis.

Authors:  Murat Gunay; Gokhan Celik; Rahim Con
Journal:  Case Rep Pediatr       Date:  2015-03-19

5.  Persistent Symblepharon in an Infant Following Epidemic Keratoconjunctivitis.

Authors:  Sezen Akkaya; Yelda Buyru Ozkurt
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2016

6.  A treatment protocol for minimizing duration and complications of adenoviral epidemic keratoconjunctivitis.

Authors:  Chidanand Kulkarni; Kirthinath Ballal
Journal:  Taiwan J Ophthalmol       Date:  2019-10-24

7.  Topical Ocular Povidone-Iodine as an Adjunctive Preventative Practice in the Era of COVID-19.

Authors:  Terrence P O'Brien; Jesse Pelletier
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.